期刊文献+

中西医结合治疗肝硬化的临床研究 被引量:8

Clinical study of liver cirrhosis treated by integrated traditional Chinese and western medicine
原文传递
导出
摘要 [目的]观察中西医结合治疗肝硬化的临床疗效。[方法]随机选取我院就诊的200例肝硬化患者进行病例对照研究,随机分为对照组和试验组,各100例,对照组按照西医分型治疗;试验组明确中医辨证分型,在对照组治疗基础上给予中药调理,患者出院后对其进行随访观察,综合评价患者的治疗效果。[结果]对照组的总有效率为65.0%,无效率35.0%,试验组的总有效率92.0%,无效率8.0%,2组比较,差异有统计学意义(P<0.05)。试验组治疗前后血清肝纤维化指标:透明质酸为(478.1±210.8)和(306.1±130.5)μg/L;层黏连蛋白(130.1±32.8)和(99.0±21.5)μg/L;Ⅲ型前胶原(195.1±32.8)和(145.1±18.6)μg/L,治疗前后比较差异均有统计学意义(P<0.05)。[结论]中医辨证结合西医常规治疗肝硬化临床效果和随访结果均优于单纯西医治疗,同时辅以针灸疗法,对防止患者病情的进一步发展效果更明显。 [Objective]To observe the clinical efficacy of liver cirrhosis treated by integrated traditional Chinese and western medicine therapy. [Methods]A total of 200 patients with liver cirrhosis were randomly divided into treatment and control groups (n= 100). Patients in control group received western medicine, while those in treatment group received Chinese blood lipids as well as B ultrasound and symptoms medicine in addition. Evaluation of liver function and of indicators before and after treatment wore performed.[Results]The total effective rate was 65% in control group and 92 % in treatment group, showing signifi- cant difference (P〈0. 05). The hyaluronic acid level in treatment group before and after treatment was re- spectively(478. 1±210.8)μg/L and (306.1±130.5)μg/L, laminin was (130. 1±32.8)μg/L and(99.0±1.5)μg/L, and type Ⅲ procollagen was (195.1±32.8)μg/L and(145.1±18.6)μg/L, all indicating sig- nificant difference (P〈0.05). CConlusion]Treatment of integrated traditional Chinese and western medi- cine has a superior effect on liver cirrhosis. Supplementation of acupuncture and moxibustion can help pre- vent further development of the disease.
作者 周红萍
出处 《中国中西医结合消化杂志》 CAS 2013年第4期199-201,共3页 Chinese Journal of Integrated Traditional and Western Medicine on Digestion
关键词 肝硬化 中西医结合疗法 临床疗效 Liver cirrhosis combination therapy of traditional Chinese and western medicine clinical efficacy
  • 相关文献

参考文献9

二级参考文献32

共引文献73

同被引文献61

  • 1漆云良,蒋萍.中西医结合治疗肝硬化顽固性腹水临床观察[J].实用中医内科杂志,2009(3). 被引量:3
  • 2危北海,张万岱,陈治水,张育轩.肝硬化中西医结合诊治方案(草案)[J].中国中西医结合杂志,2004,24(10):869-871. 被引量:215
  • 3Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1511
  • 4孙平.复方丹参注射液联合甘利欣治疗慢性乙型肝炎疗效观察[J].中医药临床杂志,2007,19(3):256-257. 被引量:2
  • 5Zhao G R,Zhang H M,Ye T X,et al.Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B[J].Food CKem Toxicol,2008,46(1):73-81.
  • 6Papastamataki M,Deiaporta P,Premetis E,et aL Evaluation of liver fibrosis in patients with thalassemia:TTie important role of hy- aluronic acid[J].Blood cells.Molecules and Disease,2010,45(3):215-218.
  • 7Vassiliadis E,Larsen DV,Clausen RE,et aL Measurement of CO3-610,a Potential liver Biomarker Derived from Matrix Metal- loproteinase-9 Degradation of collagen Type III,in a Rat Model of Reversible Carbon-Tetrachloride-Induced Fibrosis[J].Biomajric Insights,2011,6:49-58.
  • 8Vassiliadis E,Veidal SS,Simonsen H,et al.Immunological de- tection of the type V collagen propeptide fragment,PVCP-1230,in connective tissue remodeling associated with liver fibrosis[J].Biomarkers,2011,16(5):426-33.
  • 9Becatti M,Prignano F,Fiorillo G,et al.The involvement of Smac/DIABLO,p53,NF-KB,and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligo skin:Protective effects of curcumin and capsaicin[J].Antioxid Redox Signal,2010,13(9):1309-1321.
  • 10陈在忠,王红.川芎嗪抗肝纤维化作用的实验研究[J].中西医结合肝病杂志,1997,7(3):156-158. 被引量:57

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部